Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Psilocybin with Support vs Massed Prolonged Exposure Therapy for PTSD
NCT07332143Phase 2Recruiting
- Sponsor
- Emory University
- Start
- Jun 2026
- Primary completion
- Mar 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of psilocybin in post-traumatic stress disorder (PTSD), sponsored by Emory University. Started Jun 2026; status: recruiting.
02
Drugs
psilocybin
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT07332143.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07332143.